Rothschild Investment LLC’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.62K Buy
1,720
+1,400
+438% +$5.11K ﹤0.01% 2122
2026
Q1
$1.26K Buy
320
+55
+21% +$277 ﹤0.01% 2771
2025
Q4
$1.79K Buy
265
+5
+2% +$35 ﹤0.01% 2435
2025
Q3
$1.81K Buy
260
+150
+136% +$1.04K ﹤0.01% 2286
2025
Q2
$672 Sell
110
-40
-27% -$266 ﹤0.01% 2640
2025
Q1
$1.14K Buy
150
+30
+25% +$251 ﹤0.01% 2269
2024
Q4
$1.15K Sell
120
-15
-11% -$117 ﹤0.01% 2129
2024
Q3
$798 Buy
135
+60
+80% +$397 ﹤0.01% 2312
2024
Q2
$520 Buy
75
+60
+400% +$422 ﹤0.01% 1986
2024
Q1
$116 Buy
+15
New +$121 ﹤0.01% 2127

Other funds holding MDXG

Rothschild Investment LLC's MDXG Position: Q2 2026 in Review

Rothschild Investment LLC increased its MiMedx Group (MDXG) stake by 438% in Q2 2026, buying an estimated $5.11K and bringing the position to 1,720 shares worth $6.62K. The position accounts for ﹤0.01% of the portfolio, ranked #2122.

Rothschild Investment LLC first reported a position in MDXG in Q1 2024 and has held it in 10 quarters since. 226 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Rothschild Investment LLC held 1,720 shares of MiMedx Group worth $6.62K as of Q2 2026.
  • Rothschild Investment LLC bought 1,400 MiMedx Group shares in Q2 2026, an estimated $5.11K.
  • MiMedx Group made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2122 holding.
  • Rothschild Investment LLC first reported a position in MiMedx Group in Q1 2024 and has held it in 10 quarters since.
  • 226 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.